Hofmarcher, Maria M. and Röhrling, Gerald (2003) Health Policy Monitor, Pharmaceutical Price Policy. Bertelsmann Stiftung, Health Policy Monitor 2003 (2), 7 p.
oa42.pdf - Published Version
Download (36kB) | Preview
Abstract
The two main reasons for a future cost increase in the pharmaceutical sector in Austria are the demographic development and medical progress.In order to contain cost increases the policy purses two objectives: Introduction of a new price formation procedure and increased generic consumption to 20% of all prescribed drugs by 2006.
Item Type: | Discussion/ Working Paper (Unspecified) |
---|---|
Keywords: | Pharmaceutical Policy |
Date Deposited: | 06 Oct 2016 09:53 |
Last Modified: | 19 Sep 2024 08:51 |
URI: | https://irihs.ihs.ac.at/id/eprint/4075 |